Skip to main content
News & updates

Interdisciplinary Research Workshop ‘Housing and Health’ between TU Delft | Global Initiative, LCAB and LUMC Global comes to a successful close

Created on:


November 15, 2021

Last month we kicked off the pilot study on housing and health, set up by the TU Delft | Global Initiative, Leiden Center for Applied Bioscience (LCAB) and LUMC Global in which 6 groups, consisting of students from all institutes, joined forces to analyse the correlation between spatial conditions of residential neighbourhoods and buildings, and health. All groups developed a comparative analysis of two neighbourhoods in The Hague, with each group looking at different neighbourhoods. Last week, on November 10, they presented their findings and suggestions on the central theme: how do we build a pandemic proof and healthy city?

After poster presentations from all student groups, dean Prof Pancras Hogendoorn (LUMC) kicked off the end presentation round at the LUMC by giving a heartfelt introduction to all students. He stressed how valuable this pilot study was to showcase the value of interdisciplinary learning, looking at the same problem from different angles. “A project like this really highlights the things you are really good at and where you need others to fill in gaps in your knowledge”, says Hogendoorn. He closed his introduction emphasizing the importance of follow-up work and research on the urban and health project, to which one of the coordinators, Prof Nelson Mota (TU Delft), added: “This project paves the way for something bigger. We just entered the door of a big building.”

All groups then proceeded to present their work and findings, coming to interesting conclusions to create the pandemic proof and healthy city of the future, considering the influence of residential and urban density, dwelling space, biodiversity and greenery in, around and on buildings, social distance, infrastructure, outdoor air microbiodiversity and ventilation, natural light, urban form, hygiene, lifestyle, safety and mental health. A very elaborate list, although we probably missed some elements the students mentioned given how precise they went about the central problem. Even though all students worked with small samples and stated no significant conclusions could be drawn as a result, they were clearly on to something, matching exactly with the professors’ expectations and desire for follow-up research and practical work.

All in all, the five-week pilot study proved invaluable to both students and professors. The course acts as an important starting point for future collaborations between TU Delft, LUMC and LCAB, and their students. Hopefully next year, we can expand our efforts internationally (which, due to COVID-19, was not possible this year) to give the subject the substance it deserves.

To all who helped set this up, thank you! But most of all to all the students who joined and presented such wonderful work, thank you very much!


More news & updates

AE-TBC wins EDCTP’s Outstanding Research Team 2020 prize!

November 2, 2021

The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.

Semantic Technology to Ensure FAIR patient Data in Africa

November 14, 2023

LUMC and LUMC Global was represented at the 2023 Conference of the American Medical Informatics Association which opened on 12 November. Prof. Mirjam van Reisen, Prof FAIR Data Science and Erik Schultes, presented at the scientific panel on “The CEDAR Workbench: Semantic Technology to Ensure FAIR Data” alongside Mark A. Musen, M.D. from the Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford; Anthony L. Juehne, from the Office of the Director, National Institutes of Health, Bethesda; and  Rachel L. Richesson, University of Michigan Medical School, Ann Arbor.

The presentations focused on the LUMC-research on the curation of medical data to ensure data is Findable, Accessible (under well-defined conditions), Interoperable and Reusable (FAIR) and Federated AI Ready.

Janssen COVID-19 vaccine approved for use in EU on March 11

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.